BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• 

  Business

  AbbVie Doubles Down on Alzheimer’s With $1.4B Aliada Buy

  The acquisition of Aliada Therapeutics gives AbbVie access to a Phase I anti-amyloid antibody as well as the biotech’s novel platform engineered for efficient blood-brain barrier transport.

  October 28, 2024

   · 

  2 min read

   · 

  Heather McKenzie
• 

  FDA

  Evolving FDA Accelerated Approval Pathway Suffers Spate of Withdrawals

  As therapies for rare and neurological diseases earn accelerated approval, experts laud the program’s intent while remaining concerned about confirmatory trials and clinical efficacy, especially as products greenlit under this pathway are pulled from the market.

  October 28, 2024

   · 

  7 min read

   · 

  Heather McKenzie
• 

  Opinion

  New Therapies Are Set to Upend the Alpha-1 Antitrypsin Deficiency Treatment Space

  Vertex may have pivoted away from the space, but candidates in development by Arrowhead/Takeda, Wave, Korro and others could address the damage underlying alpha-1 antitrypsin deficiency and make today’s treatments a thing of the past.

  October 28, 2024

   · 

  3 min read

   · 

  Jia Jie Chen
• Press Releases

  Dentsply Sirona to Host Conference Call Regarding Update on Byte Aligner Products

  October 28, 2024

   · 

  1 min read
• Press Releases

  Sun Pharma Announces Multiple Data Presentations Highlighting its Dermatology Portfolio to be Featured at the 2024 Fall Clinical Dermatology Conference

  October 28, 2024

   · 

  5 min read
• Press Releases

  Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.

  October 28, 2024

   · 

  8 min read
• Press Releases

  Tharimmune Announces Upcoming Conference Presentations

  October 28, 2024

   · 

  4 min read
• Press Releases

  Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

  October 28, 2024

   · 

  6 min read
• Press Releases

  Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals

  October 28, 2024

   · 

  9 min read
• Press Releases

  NeoMab Fully Human Antibody Discovery Platform: A New Flexible Mouse Purchase Model Leading a New Trend in Antibody Drug Development

  October 28, 2024

   · 

  3 min read